Egle, A., Melchardt, T., Obrtlíková, P., Smolej, L., Kozák, T., Steurer, M., . . . Greil, R. (2019). Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL‐8a mabtenance trial. Cancer Med.
Chicago ZitierstilEgle, Alexander, et al. "Rituximab Maintenance Overcomes the Negative Prognostic Factor of Obesity in CLL: Subgroup Analysis of the International Randomized AGMT CLL‐8a Mabtenance Trial." Cancer Med 2019.
MLA ZitierstilEgle, Alexander, et al. "Rituximab Maintenance Overcomes the Negative Prognostic Factor of Obesity in CLL: Subgroup Analysis of the International Randomized AGMT CLL‐8a Mabtenance Trial." Cancer Med 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.